IMPROVEDD VTE risk score: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{SSH}}, {{SMP}}, {{Anmol}} | {{CMG}}; {{AE}} {{SSH}}, {{SMP}}, {{Anmol}} | ||
==Overview== | ==Overview== | ||
The IMPROVEDD VTE Risk Score,<ref>{{cite journal | author=Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. |date=2017 |title= The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification |url= https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0037-1603929#TB17006-7 |journal= TH Open |volume= 01 |issue=01 |pages= e56-e65 |doi= 10.1055/s-0037-1603929 |access-date= }}</ref> which incorporates [[D-dimer]] measurement into the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) score,<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> refines the prediction of symptomatic [[venous thromboembolism]] (including symptomatic [[deep-vein thrombosis]], nonfatal [[pulmonary embolism]], and death related to [[venous thromboembolism]]) events in acutely ill hospitalized patients up to 77 days of hospitalization. | The IMPROVEDD VTE Risk Score,<ref>{{cite journal | author=Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. |date=2017 |title= The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification |url= https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0037-1603929#TB17006-7 |journal= TH Open |volume= 01 |issue=01 |pages= e56-e65 |doi= 10.1055/s-0037-1603929 |access-date= }}</ref> which incorporates [[D-dimer]] measurement into the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) score,<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> refines the prediction of symptomatic [[venous thromboembolism]] (including symptomatic [[deep-vein thrombosis]], nonfatal [[pulmonary embolism]], and death related to [[venous thromboembolism]]) events in acutely ill hospitalized patients up to 77 days of hospitalization. | ||
==IMPROVEDD VTE Risk Score Calculator== | ==IMPROVEDD VTE Risk Score Calculator== | ||
=== Calculation of the IMPROVEDD Score for VTE === | === Calculation of the IMPROVEDD Score for VTE === | ||
Please check the boxes that apply to calculate the IMPROVEDD VTE Risk score and symptomatic VTE risk up to 77 days after hospitalization: | Please check the boxes that apply to calculate the IMPROVEDD VTE Risk score and symptomatic VTE risk up to 77 days after hospitalization: | ||
{{#widget:IMPROVEDDScore}} | {{#widget:IMPROVEDDScore}} | ||
===Interpretation of the IMPROVEDD Score for VTE=== | ===Interpretation of the IMPROVEDD Score for VTE=== | ||
| Line 19: | Line 15: | ||
* Score = 4: Predicted Risk of Symptomatic VTE is 1.6% at 35-42 days and 1.9% at 77 days | * Score = 4: Predicted Risk of Symptomatic VTE is 1.6% at 35-42 days and 1.9% at 77 days | ||
* Score ≥ 5: Predicted Risk of Symptomatic VTE is 2.2% at 35-42 days and 2.7% at 77 days | * Score ≥ 5: Predicted Risk of Symptomatic VTE is 2.2% at 35-42 days and 2.7% at 77 days | ||
==References== | |||
== | |||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Cardiology]] | |||
[[Category:Hematology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Primary care]] | |||
[[Category:Calculator]] | |||
Revision as of 00:47, 6 November 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2], Seyedmahdi Pahlavani, M.D. [3], Anmol Pitliya, M.B.B.S. M.D.[4]
Overview
The IMPROVEDD VTE Risk Score,[1] which incorporates D-dimer measurement into the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) score,[2] refines the prediction of symptomatic venous thromboembolism (including symptomatic deep-vein thrombosis, nonfatal pulmonary embolism, and death related to venous thromboembolism) events in acutely ill hospitalized patients up to 77 days of hospitalization.
IMPROVEDD VTE Risk Score Calculator
Calculation of the IMPROVEDD Score for VTE
Please check the boxes that apply to calculate the IMPROVEDD VTE Risk score and symptomatic VTE risk up to 77 days after hospitalization:
Interpretation of the IMPROVEDD Score for VTE
The interpretation of the score is as follows:
- Score = 0: Predicted Risk of Symptomatic VTE is 0.4% at 35-42 days and 0.5% at 77 days
- Score = 1: Predicted Risk of Symptomatic VTE is 0.6% at 35-42 days and 0.7% at 77 days
- Score = 2: Predicted Risk of Symptomatic VTE is 0.8% at 35-42 days and 1.0% at 77 days
- Score = 3: Predicted Risk of Symptomatic VTE is 1.2% at 35-42 days and 1.4% at 77 days
- Score = 4: Predicted Risk of Symptomatic VTE is 1.6% at 35-42 days and 1.9% at 77 days
- Score ≥ 5: Predicted Risk of Symptomatic VTE is 2.2% at 35-42 days and 2.7% at 77 days
References
- ↑ Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. (2017). "The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification". TH Open. 01 (01): e56–e65. doi:10.1055/s-0037-1603929.
- ↑ Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH; et al. (2011). "Predictive and associative models to identify hospitalized medical patients at risk for VTE". Chest. 140 (3): 706–14. doi:10.1378/chest.10-1944. PMID 21436241.